MS21570 is primarily utilized in research and development within the field of oncology. It functions as a selective inhibitor targeting specific enzymes or pathways involved in cancer cell proliferation. Its application is significant in preclinical studies, where it is used to investigate the mechanisms of tumor growth and to evaluate the efficacy of potential therapeutic strategies. Researchers employ MS21570 to understand its impact on cellular processes and to assess its potential as a lead compound for developing new anticancer drugs. Additionally, it may be used in combination with other agents to study synergistic effects in inhibiting cancer progression. Its role in advancing cancer research makes it a valuable tool in the quest for innovative treatments.